Overview and Scope
Typhoid antibody testing is a diagnostic procedure designed to detect antibodies against Salmonella enterica serotype Typhi, the bacterium responsible for causing typhoid fever. The primary aim of typhoid antibody testing is to diagnose typhoid fever by identifying the immune response (antibodies) to Salmonella Typhi. Typhoid antibody testing helps to provide timely and accurate diagnosis, enabling appropriate treatment and management of the disease.
Sizing and Forecast
The typhoid antibody testing market size has grown strongly in recent years. It will grow from $7.27 billion in 2023 to $7.83 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising collaborative effort aimed at the development of new testing tools, rise in developing countries, increasing competition, cost effective diagnostic kits, and government support.
The typhoid antibody testing market size is expected to see strong growth in the next few years. It will grow to $10.61 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing prevalence of the disease, increasing rate of morbidity and mortality, travel-related testing, increasing healthcare spending, and growing awareness about typhoid fever among healthcare professionals and the public. Major trends in the forecast period include advanced technologies, global health initiatives, emphasis on outbreak preparedness and surveillance, growing work toward the development of novel typhoid antibody tests, and rise in healthcare spending.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report
Segmentation & Regional Insights
The typhoid antibody testing market covered in this report is segmented –
1) By Product Type: Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test
2) By Paratyphi Type: Paratyphi A, Paratyphi B, Paratyphi C
3) By End-User: Hospitals, Serological Testing Centers, Clinics, Diagnostic Centers, Other End Users
Asia-Pacific was the largest region in the typhoid antibody testing market in 2023. The regions covered in the typhoid antibody testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16815&type=smp
Major Driver Impacting Market Growth
The rise in waterborne diseases is expected to propel the growth of the typhoid antibody testing market going forward. Waterborne diseases refer to illnesses caused by pathogenic microorganisms transmitted through contaminated water. The rise in waterborne diseases is due to poor sanitation and hygiene, lack of access to clean drinking water, rapid urbanization, climate change, and agricultural runoff. Typhoid antibody testing helps in the early diagnosis, confirmation, and monitoring of treatment efficacy of typhoid fever, aiding in the identification of carriers and implementation of preventive measures, playing a crucial role in managing and controlling waterborne diseases. For instance, according to the Coalition against Typhoid, a US-based organization dedicated to preventing typhoid and other invasive salmonellosis, from January to August 2022, the Philippines recorded 7,681 typhoid (a waterborne disease) cases, marking a 109% increase compared to the same period in the previous year. Therefore, the rise in waterborne diseases is driving the growth of the typhoid antibody testing market.
Key Industry Players
Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc. , Abbott Laboratories, Siemens Healthineers AG , Becton Dickinson and Company, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, The Native Antigen Company, AroCell, AccuBioTech Co. Ltd, Vanguard Diagnostics private limited., Atlas Medical , Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics
The typhoid antibody testing market report table of contents includes:
1. Executive Summary
2. Typhoid Antibody Testing Market Characteristics
3. Typhoid Antibody Testing Market Trends And Strategies
4. Typhoid Antibody Testing Market – Macro Economic Scenario
5. Global Typhoid Antibody Testing Market Size and Growth
.
.
.
32. Global Typhoid Antibody Testing Market Competitive Benchmarking
33. Global Typhoid Antibody Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Typhoid Antibody Testing Market
35. Typhoid Antibody Testing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
